Xeno Transplants Corp

Xeno Transplants Corp is located in Vancouver, Canada on 1066 Hastings St W Suite 2610. Xeno Transplants Corp is rated 3 out of 5 in the category pharmaceuticals in Canada. Xeno Transplants Corporation, formerly Icon Development, Inc., is a bio-technology research and development company that holds an exclusive commercial license from Massachusetts General Hospital derived from over 15 years of development in the field of xenotransplantation by Novartis Pharmaceuticals and its associated research entities. The Company intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources. As at June 30, 2007, the Company does not have any material business operations. American Xeno Inc. (AXI), a bio-technology research and development company, is a wholly owned subsidiary of the Company. On January 31, 2007, AXI acquired a patent assignment from Infigen, Inc. consisting of two issued United States and seven issued international patents and multiple patent applications relating to producing pigs by cloning.